Biomind Labs Inc BMNDF
Trading Information
- Previous Close Price
- $0.49
- Day Range
- $0.46–0.46
- 52-Week Range
- $0.01–0.80
- Bid/Ask
- $0.25 / $0.90
- Shares Outstanding
- 77.57M
- Market Cap
- $35.68M
- Volume/Avg
- 12,013 / 8,127
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.biomindlabs.com
Valuation
|
Metric
|
BMNDF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BMNDF
Financial Strength
|
Metric
|
BMNDF
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −19.57 |
Quick Ratio
BMNDF
Profitability
|
Metric
|
BMNDF
|
|---|---|
Return on Assets (Normalized) | −7,566.34% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BMNDF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|H#Z>Y! | LOCK|^%NL | $129B | |||
| Moderna Inc
MRNA
| LOCK|Tm?#@^& | LOCK|pt^ | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|?Z&Trk@ | LOCK|f!@?? | $77B | |||
| argenx SE ADR
ARGX
| LOCK|x!#MFx< | LOCK|mBd | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|XlGN<m# | LOCK|R% | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|qNW@YWj | LOCK|j@@< | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|%qLZ$Sp& | LOCK|!LLCz | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|rMyKhg | LOCK|l&d | $24B | |||
| Incyte Corp
INCY
| LOCK|Z^D>&r | LOCK|>p | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|F$Q^?H | LOCK|MGw | $14B |
United States